420 related articles for article (PubMed ID: 33506055)
1. Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.
de Araújo ND; Gama FM; de Souza Barros M; Ribeiro TLP; Alves FS; Xabregas LA; Tarragô AM; Malheiro A; Costa AG
J Immunol Res; 2021; 2021():6633824. PubMed ID: 33506055
[TBL] [Abstract][Full Text] [Related]
2. Unconventional T cells - New players in antifungal immunity.
Dunne MR; Wagener J; Loeffler J; Doherty DG; Rogers TR
Clin Immunol; 2021 Jun; 227():108734. PubMed ID: 33895356
[TBL] [Abstract][Full Text] [Related]
3. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG
Front Immunol; 2021; 12():729085. PubMed ID: 34630403
[TBL] [Abstract][Full Text] [Related]
4. Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy.
Bohineust A; Tourret M; Derivry L; Caillat-Zucman S
Bull Cancer; 2021 Oct; 108(10S):S92-S95. PubMed ID: 34920812
[TBL] [Abstract][Full Text] [Related]
5. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
6. Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.
Allegra A; Casciaro M; Lo Presti E; Musolino C; Gangemi S
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740879
[TBL] [Abstract][Full Text] [Related]
7. Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection.
Magnoumba M; Singh A; Ogongo P; Roider J; Asowata O; Fehlings M; Karim F; Ndung'u T; Anderson F; Leslie A; Kløverpris H
Front Immunol; 2020; 11():579743. PubMed ID: 33117384
[TBL] [Abstract][Full Text] [Related]
8. Role of CD1d- and MR1-Restricted T Cells in Asthma.
Iwamura C; Nakayama T
Front Immunol; 2018; 9():1942. PubMed ID: 30210497
[TBL] [Abstract][Full Text] [Related]
9. Swine unconventional T cells.
Wu M; Jiang Q; Nazmi A; Yin J; Yang G
Dev Comp Immunol; 2022 Mar; 128():104330. PubMed ID: 34863955
[TBL] [Abstract][Full Text] [Related]
10. Unconventional T Cell Targets for Cancer Immunotherapy.
Godfrey DI; Le Nours J; Andrews DM; Uldrich AP; Rossjohn J
Immunity; 2018 Mar; 48(3):453-473. PubMed ID: 29562195
[TBL] [Abstract][Full Text] [Related]
11. The burgeoning family of unconventional T cells.
Godfrey DI; Uldrich AP; McCluskey J; Rossjohn J; Moody DB
Nat Immunol; 2015 Nov; 16(11):1114-23. PubMed ID: 26482978
[TBL] [Abstract][Full Text] [Related]
12. Unconventional T cells and kidney disease.
Kaminski H; Couzi L; Eberl M
Nat Rev Nephrol; 2021 Dec; 17(12):795-813. PubMed ID: 34446934
[TBL] [Abstract][Full Text] [Related]
13. The duplexity of unconventional T cells in cancer.
Lawrence M; Wiesheu R; Coffelt SB
Int J Biochem Cell Biol; 2022 May; 146():106213. PubMed ID: 35447350
[TBL] [Abstract][Full Text] [Related]
14. Human blood MAIT cell subsets defined using MR1 tetramers.
Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells and unconventional T cells in COVID-19.
Björkström NK; Ponzetta A
Curr Opin Virol; 2021 Aug; 49():176-182. PubMed ID: 34217135
[TBL] [Abstract][Full Text] [Related]
16. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
17. The dialogue between unconventional T cells and the microbiota.
Lin Q; Kuypers M; Philpott DJ; Mallevaey T
Mucosal Immunol; 2020 Nov; 13(6):867-876. PubMed ID: 32704035
[TBL] [Abstract][Full Text] [Related]
18. Tissue-resident lymphocytes: from adaptive to innate immunity.
Sun H; Sun C; Xiao W; Sun R
Cell Mol Immunol; 2019 Mar; 16(3):205-215. PubMed ID: 30635650
[TBL] [Abstract][Full Text] [Related]
19. Distal
Figueroa MG; Parker LM; Krol K; Zhao M
Immunohorizons; 2021 Sep; 5(9):772-781. PubMed ID: 34583938
[TBL] [Abstract][Full Text] [Related]
20. NKT cells - New players in CAR cell immunotherapy?
Kriegsmann K; Kriegsmann M; von Bergwelt-Baildon M; Cremer M; Witzens-Harig M
Eur J Haematol; 2018 Dec; 101(6):750-757. PubMed ID: 30187578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
